Equity
€18,550 from €130,807 in 2021
Equity fell by 86% in 4 years.
Dr. Katrien Devos
Lifetime
7 annual accounts with figures on one time axispeak €187,148 (2024)
€174,438▼ 6.8%
peak €119,335 (2024)
€105,173▼ 11.9%
peak €130,807 (2021)
€18,550unchanged
€198,464▼ 27.5%
Board1 name since 2018
1 directorKatrien DEVOS
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Dividend €105,173Debts from €273,587 to €198,464Cash from €159,083 to €69,659
Key points
from the 2025 annual accountsTurnover
≈ €350,000 estimated
The micro format states no turnover.
Debts
€198,464 91% of the balance sheet
Financial debts 17%Suppliers 1%Taxes and wages 1%Other 82%
Of this, €161,899 falls due within a year.
Investments
€62,247 1.5 × depreciation
Green is investment, beige is depreciation.
Filings
7 annual accounts 4 late
The 2019 accounts came latest: 83 days after the end of the period.
Position in the sector
8.5%
Lower solvency than 87% of companies in human health. Sector median 63.0% · 20,774 companies.
Checked score
92
Excellent
Financially stronger than 37% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024lowest value
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: 0.1%▲ +0.1 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025highest value
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: < 0.1%▼ -0.1 percentage points vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Equity €18,550 (8.5% of total assets)
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €217,014
Liquidity: current ratio 0.74, cash €69,659, halved
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 13% of them on solvency, 18% on liquidity, 80% on profitability and 37% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 2,153 companies had the same profile as Dr. Katrien Devos has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.2%
stopped another way
1.7%
went bankrupt
The bankruptcy probability of Dr. Katrien Devos itself is lower: < 0.1% within 12 months. It rests on far more data about Dr. Katrien Devos than the profile alone.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,153 companies, not a prediction for Dr. Katrien Devos. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.74 (0.8 in 2024), below 1. Short-term debt is 74.6% and cash 32.1% of total assets. 91.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 20774 sector peers (2025).
NBB · sector comparisonPosition among 20774 sector peers
Solvency
better than 13%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
31 days early
2024
28 days late
2023
27 days late
2022
31 days late
2021
58 days early
2020
18 days early
2019
83 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 9 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (4 of the last 5 accounts filed within 59 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0716858209
Change of role: Katrien DEVOS, from manager to director
Director discharge: Katrien DEVOS · Gazette deed
Publication in the Belgian Official Gazette
Gazette deed
Incorporation
Founding capital of €18,550, 100 shares, €12,400 paid up · Founder: DEVOS KatrienAgnesEsther · Appointment: Katrien Devos (manager) · published on 28-12-2018 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. Katrien Devos Ypres | €217,014 | €174,438 | 8.5% | - |
| Dr. MATTHIAS VERYSER Ypres | €213,483 | €171,481 | 58.4% | - |
| Dr. Gert-Jan Aelvoet Roeselare | €233,819 | €164,799 | 61.2% | - |
| Dr. Jan Bontinck - Vasculair chirurg Ghent | €222,064 | €175,901 | 51.9% | - |
| Dr. Marjan DHOLLANDER Stekene | €230,160 | €182,670 | 38.4% | - |
| MEDISCH CENTRUM OOST Malle | €222,620 | €184,141 | 6.3% | 2.8 |
| DOKTER INGE RUYTINX Halen | €195,313 | €164,548 | 68.8% | 0 |
These companies have the same main activity as Dr. Katrien Devos: general medical practice (NACE 86210). They are comparable in size and age: total assets between €195,000 and €234,000, founded between 2018 and 2019.
Official details
Source: KBO- Status
- Active since 26-12-2018Normal situation
- Activity
- General medical practiceNACE 86210and 1 other
- Establishment unit
- 2.283.585.1838900 Ypres, since 26-12-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 03-12-2025
Annual accounts 2025
- €217,014▼ 25.7%
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on Dr. Katrien Devos
Dr. Katrien Devos files the micro format. That format states no turnover. The gross margin rose from €87,412 in 2019 to €174,438 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. Katrien Devos
- What is the company number of Dr. Katrien Devos?
- The company number of Dr. Katrien Devos is 0716.858.209. The VAT number is the same number with BE in front: BE 0716.858.209.
- Where is Dr. Katrien Devos based?
- The registered office is at Memlingdreef 3, 8900 Ypres.Company details
- What does Dr. Katrien Devos do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Dr. Katrien Devos?
- Dr. Katrien Devos is a private limited company (BV).
- When was Dr. Katrien Devos founded?
- Dr. Katrien Devos was founded on 26-12-2018.
- Is Dr. Katrien Devos still active?
- Yes, Dr. Katrien Devos is an active enterprise in the KBO register.
- What is the turnover of Dr. Katrien Devos?
- The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €174,438 and 65 comparable companies (NACE 862). It probably lies between €260,000 and €440,000.Financials
- Is Dr. Katrien Devos profitable?
- In financial year 2025, Dr. Katrien Devos made a profit of €105,173.
- Where can I find the annual accounts of Dr. Katrien Devos?
- Dr. Katrien Devos filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. Katrien Devos due?
- Dr. Katrien Devos must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.